Article
Influence of smoking and CYP2C19 genotypes on H. pylori eradication success.
Epidemiology and infection - 1 Jan 2007
Suzuki T, Matsuo K, Sawaki A, Wakai K, Hirose K, Ito H, Saito T, Nakamura T, Yamao K, Hamajima N, Tajima K
Abstract excerpt
CYP2C19 polymorphisms and smoking influence the efficacy of H. pylori eradication therapy, but interaction between the two have hitherto not been examined. A total of 142 H. pylori-positive patients who received triple drug therapy with lansoprazole, amoxicillin and clarithromycin were categorized into three groups with regard to diplotypes of CYP2C19: homozygous extensive metabolizer (homEM), heterozygous EM...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
